A ‘Mistake’ May Have Made a More Efficacious COVID-19 Vaccine
AstraZeneca probes 'mistake' behind 90% COVID-19 vaccine efficacy https://t.co/AaJ2LnNxDJ
— Carol Duff (@CarolDuff18) November 26, 2020
Health Editor’s Note: Surprising information on the COVID-19 vaccine front. AstraZeneca is investigating why one-half dose of the primer vaccine seems to have raised the efficacy of the vaccine. While the half-dose was an error, this dose seems to have been as effective as two full doses and the hypothesis is that the lower dose ‘primed’ the immune system and created a super immune reaction. Sometimes mistakes happen for a reason as we move toward an effective, safe vaccine against COVID-19…..Carol
Carol graduated from Riverside White Cross School of Nursing in Columbus, Ohio and received her diploma as a registered nurse. She attended Bowling Green State University where she received a Bachelor of Arts Degree in History and Literature. She attended the University of Toledo, College of Nursing, and received a Master’s of Nursing Science Degree as an Educator.
She has traveled extensively, is a photographer, and writes on medical issues. Carol has three children RJ, Katherine, and Stephen – one daughter-in-law; Katie – two granddaughters; Isabella Marianna and Zoe Olivia – and one grandson, Alexander Paul. She also shares her life with her husband Gordon Duff, many cats, and two rescues.
ATTENTION READERS
We See The World From All Sides and Want YOU To Be Fully InformedIn fact, intentional disinformation is a disgraceful scourge in media today. So to assuage any possible errant incorrect information posted herein, we strongly encourage you to seek corroboration from other non-VT sources before forming an educated opinion.
About VT - Policies & Disclosures - Comment Policy
In the low-dose trial, none of the participants were over 55 years old and the efficacy was 90%. In the full-dose trial the efficacy was 62%. Could this suggest that the vaccine is less effective in the older population that is said to be at an increased risk if they contract Covid-19?
Since only one of the two doses in the low-dose trial was a half-dose, perhaps it would be informative to test what happens if both doses are half-doses. Also, if the first dose as a half-dose was better than the first dose as a full-dose could a first dose at a quarter-dose produce better results than having the first dose as a half-dose?
Comments are closed.